Hecheng Li
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China · Ruijin Hospital · Ruijin Hospital Shanghaijiaotong University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
15
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers in non-small cell lung cancer
57
PubMed author-name match
Trials
Studies that name Hecheng Li as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07890636 · Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLCRuijin Hospital · not yet recruiting · Lung Neoplasm Malignant · study chair
- Ph3NCT07888140 · Modular Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal CancerRuijin Hospital · recruiting · Esophageal Cancer · principal investigator
- N/ANCT07004634 · Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE）Ruijin Hospital · recruiting · Esophageal Cancer, Drainage/Methods, Postoperative Pain · principal investigator
- Ph3NCT06339060 · An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).Ruijin Hospital · recruiting · Esophageal Cancer · principal investigator
- Ph2NCT06269211 · Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive ExpressionRuijin Hospital · recruiting · Carcinoma, Non-Small-Cell Lung · principal investigator
- N/ANCT05662553 · ENB Guided MWA Combined With VATS Versus Sequential Surgery for Synchronous Bilateral Multiple Primary Lung NodulesRuijin Hospital · unknown · Multiple Primary Lung Cancer · principal investigator
- Ph2NCT04982900 · Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass OpacitiesRuijin Hospital · unknown · Multiple Primary Lung Cancers · principal investigator
- N/ANCT04973293 · Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung CancerRuijin Hospital · recruiting · Lung Neoplasm Malignant · principal investigator
- N/ANCT04529603 · The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality TechnologyRuijin Hospital · withdrawn · Lung Neoplasm · principal investigator
- Ph3NCT04513418 · Effects of Preoperative Enteral Immunonutrition for Esophageal Cancer Patients Given Neoadjuvant ChemoradiotherapyHecheng Li M.D., Ph.D · active not recruiting · Esophageal Neoplasms · principal investigator
- Ph2NCT04435197 · Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell CarcinomaRuijin Hospital · completed · Esophageal Squamous Cell Carcinoma · principal investigator
- N/ANCT04211051 · Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary NodulesRuijin Hospital · completed · Lung Neoplasms · principal investigator
- Ph1NCT03792347 · Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of EsophagusHecheng Li M.D., Ph.D · completed · Esophageal Squamous Cell Carcinoma · principal investigator
- N/ANCT03192904 · Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in SegmentectomyRuijin Hospital · terminated · Segmentectomy · principal investigator
- Ph3NCT03094351 · Robot-assisted Esophagectomy Versus Conventional Thoracoscopic EsophagectomyShanghai Chest Hospital · unknown · Esophageal Cancer, Esophageal Carcinoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in non-small cell lung cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:04 UTC. The ranking covers the 200 most relevant of 57 PubMed records, and a shared surname and initials can bring in a namesake. All 57 on PubMed
- FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.Oncologist · 2017253 citationsRCR 7.5
- Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.JAMA Oncol · 2017129 citationsRCR 4.6
- Robotic-assisted Versus Video-assisted Thoracoscopic Lobectomy: Short-term Results of a Randomized Clinical Trial (RVlob Trial).Ann Surg · 2022121 citationsRCR 11.2
- WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.Cancer Immunol Immunother · 2010104 citationsRCR 2.3
- Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.Cancer Immunol Immunother · 2012101 citationsRCR 2.4
- Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery.Cytotherapy · 200993 citationsRCR 2.0
- Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.Cancer Immunol Immunother · 201389 citationsRCR 2.1
- Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys · 201872 citationsRCR 3.3
- Traditional Chinese Medicine treatment as maintenance therapy in advanced non-small-cell lung cancer: A randomized controlled trial.Complement Ther Med · 201671 citationsRCR 2.5
- Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.Immunol Res · 201763 citationsRCR 2.0